A Phase II Trial of Piroxantrone in Advanced Ovarian Carcinoma after Failure of Platinum-Based Chemotherapy: Southwest Oncology Group Study 8904

MLA

Anne Marie Maddox, et al. “A Phase II Trial of Piroxantrone in Advanced Ovarian Carcinoma after Failure of Platinum-Based Chemotherapy: Southwest Oncology Group Study 8904.” Gynecologic Oncology, vol. 57, June 1995, pp. 407–11. EBSCOhost, https://doi.org/10.1006/gyno.1995.1163.

APA

Anne Marie Maddox, Alexander Hantel, David S. Alberts, P. Y. Liu, Kathy S. Albain, James L. Wade, Elizabeth Poplin, & Robert V. O’Toole. (1995). A Phase II Trial of Piroxantrone in Advanced Ovarian Carcinoma after Failure of Platinum-Based Chemotherapy: Southwest Oncology Group Study 8904. Gynecologic Oncology, 57, 407–411. https://doi.org/10.1006/gyno.1995.1163

Chicago

Anne Marie Maddox, Alexander Hantel, David S. Alberts, P. Y. Liu, Kathy S. Albain, James L. Wade, Elizabeth Poplin, and Robert V. O’Toole. 1995. “A Phase II Trial of Piroxantrone in Advanced Ovarian Carcinoma after Failure of Platinum-Based Chemotherapy: Southwest Oncology Group Study 8904.” Gynecologic Oncology 57 (June): 407–11. doi:10.1006/gyno.1995.1163.